Alemtuzumab lessens relapses, improves disability in MS - studies
Two new trials offer proof that a leukemia drug long used to treat multiple sclerosis works better than a common treatment.
When compared with the widely used drug interferon beta, the leukemia drug alemtuzumab reduced relapse rates by half, researchers say.
Alemtuzumab Reverses Disability in Some
Alemtuzumab has been used to treat MS for close to two decades, but it has never been approved for ...